What are the recommended pre-treatment screening and monitoring protocols for patients starting biologic therapy in rheumatology?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18183909
Cited by: 0

Abstract

Comprehensive pre-treatment screening and ongoing monitoring are essential for patients starting biologic therapy in rheumatology to manage infection risks and ensure safety and efficacy.

Fields of Study & Subjects

Rheumatoid Arthritis Research and Therapies Musculoskeletal Disorders and Rehabilitation Hematological disorders and diagnostics

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
8 January 2026